Skip to main content

Table 1 Baseline characteristics of study participants (N = 2383)

From: Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

 

N (%)

Sociodemographics

 Age (years): mean (SD)

33·1 (9·3)

 Female gender

1372 (57·6)

Education

 None, primary or some high school

1300 (54·6)

 Completed high school or higher degree

1079 (45·4)

Marital status

 Married

150 (6·3)

 Single (never married)

2211 (92·8)

 Widowed/Divorced

22 (0·9)

Number of children (N = 2368)

 No children

448 (18·9)

 1 child

795 (33·6)

  ≥ 2 children

1125 (47·5)

 Employed

1026 (43·0)

Income level (South African rand/month) (N = 2360)

  < 2000 rand (< USD $150)

1785 (75·6)

  > 2000 rand (> USD $150)

575 (24·4)

HIV and Medical History

 Previously tested HIV

1705 (71·7)

 Previously tested HIV positive, among those tested (N = 1694)

430 (25·4)

Partner HIV status (N = 2374)

 Unknown

1315 (55·4)

 HIV-negative

390 (16·4)

 HIV-positive

669 (28·2)

 Ever tested Cryptococcus positive

5 (0·2)

 Ever received Cryptococcus treatment, among those tested positive (N = 5)

3 (60·0)

Clinical and Laboratory Testing

 CD4 count (cells/mm3): median (IQR)

317 (173, 491)

  < 100 cells/mm3

325 (13·6)

 100–199 cells/mm3

354 (14·9)

 200+ cells/mm3

1656 (69·5)

 Not available

48 (2·0)

Laboratory-based serum Cryptococcal Antigen EIA (N = 1308)

 Positive

15 (1·1)

 Negative

1294 (98·8)

  1. EIA—enzyme immunoassay; POC—point-of-care